ALTRINSIC GLOBAL ADVISORS LLC – Ionis Pharmaceuticals, Inc. Transaction History
ALTRINSIC GLOBAL ADVISORS LLC portfolio value:
$7.13M
portfolio value
ALTRINSIC GLOBAL ADVISORS LLC quarter portfolio value change:
+19.48%
quarter
Ionis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -13.52% | -25.20K shares | 229K | $44.23 | 161.24K |
| Q2 2022 | share | Decrease | -10.43% | -21.70K shares | -807K | $37.02 | 186.45K |
| Q1 2022 | share | Decrease | -47.88% | -191.23K shares | -4.44M | $37.04 | 208.15K |
| Q4 2021 | share | Decrease | -10.23% | -45.49K shares | -2.76M | $30.54 | 399.39K |
| Q3 2021 | share | Decrease | -2.49% | -11.33K shares | -3.27M | $33.54 | 444.88K |
| Q2 2021 | share | Increase | +3.44% | 15.17K shares | -1.63M | $39.89 | 456.22K |
| Q1 2021 | share | Increase | +28.67% | 98.28K shares | 449K | $44.96 | 441.05K |
| Q4 2020 | share | Decrease | -0.34% | -1.17K shares | 3.06M | $56.54 | 342.77K |
| Q3 2020 | share | Increase | +0.90% | 3.05K shares | -3.77M | $47.45 | 343.95K |
| Q2 2020 | share | Decrease | -2.27% | -7.93K shares | 3.60M | $58.96 | 340.9K |
| Q1 2020 | share | Increase | +28.45% | 77.26K shares | 87K | $47.28 | 348.83K |
| Q4 2019 | share | Decrease | -6.10% | -17.63K shares | -920K | $60.41 | 271.56K |
| Q3 2019 | share | Increase | +61.73% | 110.38K shares | 5.83M | $59.91 | 289.19K |
| Q2 2019 | share | Decrease | -24.76% | -58.83K shares | -7.79M | $64.27 | 178.81K |
| Q1 2019 | share | Decrease | -55.01% | -290.61K shares | -9.26M | $81.17 | 237.64K |
| Q4 2018 | share | Increase | +0.77% | 4.04K shares | 1.51M | $54.06 | 528.25K |
| Q3 2018 | share | Increase | +0.52% | 2.70K shares | 5.30M | $51.58 | 524.21K |
| Q2 2018 | share | Increase | +17.96% | 79.39K shares | 2.24M | $41.67 | 521.51K |
| Q1 2018 | share | Decrease | -4.83% | -22.43K shares | -3.87M | $44.08 | 442.12K |
| Q4 2017 | share | Decrease | -23.14% | -139.89K shares | -7.27M | $50.3 | 464.56K |
| Q3 2017 | share | Decrease | -10.46% | -70.63K shares | -3.69M | $50.7 | 604.45K |
| Q2 2017 | share | Decrease | -15.76% | -126.28K shares | 2.12M | $50.87 | 675.08K |
| Q1 2017 | share | Decrease | -13.00% | -119.79K shares | -11.84M | $40.2 | 801.37K |
| Q4 2016 | share | Decrease | -10.87% | -112.30K shares | 6.19M | $47.83 | 921.17K |
| Q3 2016 | share | Decrease | -24.64% | -337.89K shares | 5.92M | $36.64 | 1.03M |
| Q2 2016 | share | Increase | +121.95% | 753.49K shares | 6.91M | $23.29 | 1.37M |
| Q1 2016 | share | Increase | +197.41% | 410.12K shares | 12.15M | $40.5 | 617.88K |